• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMG:GR

129.660 EUR 6.000 4.42%

As of 10:54:35 ET on 12/23/2014.

Snapshot for Amgen Inc (AMG)

Open: 134.927 Day's Range: 127.000 - 135.900 Volume: 6,131
Previous Close: 135.660 52wk Range: 78.620 - 140.790 1-Yr Rtn: +58.36%

Stock Chart for AMG

No chart data available.
  • AMG:GR 127.044
  • 1D
  • 1M
  • 1Y
135.660
Interactive AMG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.3581
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 8.5990
Est. PEG Ratio 1.9191
Market Cap (M EUR) 98,628.47
Shares Outstanding (M) 760.67
30 Day Average Volume 7,302
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.00%
Cash Dividend (USD) 0.7900
Dividend Ex-Date 02/10/2015
5 Year Dividend Growth -
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMG

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Robert A Bradway "Bob"Chairman/President/CEODavid W MelineExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Global Commercial OpsBrian M McNameeExec VP:Full Potential Initiatives
More Company Profile & Key Executives for AMG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil